Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00307_DB00603_nanopub.RAmXE7uPL059vEhustsd93ACZkl_zpGoP02YT6ON6odm4#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00307_DB00603 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00307_DB00603 label "DDI between Bexarotene and Medroxyprogesterone Acetate - Bexarotene may decrease the serum concentration of Contraceptives (Progestins). Since bexarotene is teratogenic and can lower serum concentrations of medroxyprogesterone, it is advised that women of childbearing potential use two forms of contraception (including at least one non-hormonal form). [drugbank_resource:DB00307_DB00603]" assertion.
- drugbank_resource:DB00307_DB00603 identifier "drugbank_resource:DB00307_DB00603" assertion.
- drugbank_resource:DB00307_DB00603 title "DDI between Bexarotene and Medroxyprogesterone Acetate - Bexarotene may decrease the serum concentration of Contraceptives (Progestins). Since bexarotene is teratogenic and can lower serum concentrations of medroxyprogesterone, it is advised that women of childbearing potential use two forms of contraception (including at least one non-hormonal form)." assertion.
- drugbank:DB00307 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00307_DB00603 assertion.
- drugbank:DB00603 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00307_DB00603 assertion.